Processa Pharmaceuticals, Inc. Effective Tax Rate
Processa Pharmaceuticals, Inc. (PCSA) reported Effective Tax Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-03-18
- Processa Pharmaceuticals, Inc. effective income tax rate reconciliation, percent for fiscal 2025 was 0.00%.
- Processa Pharmaceuticals, Inc. effective income tax rate reconciliation, percent for fiscal 2024 was 0.00%.
- Processa Pharmaceuticals, Inc. effective income tax rate reconciliation, percent for fiscal 2023 was 0.00%.
- Processa Pharmaceuticals, Inc. effective income tax rate reconciliation, percent for fiscal 2022 was 0.00%, a 100.00% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-03-18 | |
| 2024-12-31 | 0.00% 10-K · filed 2026-03-18 | |
| 2023-12-31 | 0.00% 10-K · filed 2025-03-20 | |
| 2022-12-31 | 0.00% 10-K · filed 2024-03-29 | |
| 2021-12-31 | 4.44% 10-K · filed 2023-03-30 | 4.43% 10-K · filed 2022-03-30 |
| 2020-12-31 | 6.49% 10-K · filed 2022-03-30 | |
| 2019-12-31 | 15.22% 10-K · filed 2021-03-25 | |
| 2018-12-31 | 19.35% 10-K · filed 2020-03-06 | -19.35% 10-K · filed 2019-03-28 |
| 2017-12-31 | 0.00% 10-K/A · filed 2019-04-08 | |
| 2016-12-31 | 0.00% 10-K · filed 2018-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |